Page 5 - Heart Failure Guidelines
P. 5

Pediatric Heart Failure Guidelines

                  Additional Evaluation for Patient with Chemotherapy Induced Cardiomyopathy ....................26
                  Medical Management Chemotherapy Induced Cardiomyopathy ............................................26
                  Follow-up Schedule for Chemotherapy Induced Cardiomyopathy ..........................................26

               Neuromuscular Disorder Associated Cardiomyopathy ..............................................................27
                  Additional Evaluation for Patient with Neuromuscular Disorder associated Cardiomyopathy .27

               Introduction ...............................................................................................................................27
               Initial Evaluation ........................................................................................................................27
               Ongoing Management ...............................................................................................................27
                  Dose escalation plan (outpatient monitoring) .........................................................................28

               Imaging .....................................................................................................................................29
               Arrhythmia Screening ................................................................................................................29
               Advanced Therapies .................................................................................................................29
               Myocarditis ................................................................................................................................30
                  Additional Evaluation for possible Myocarditis .......................................................................30
                  Medical Management Myocarditis .........................................................................................30
                  Immunotherapy Management Myocarditis .............................................................................30
                  Follow-up Schedule for Myocarditis .......................................................................................31
               Medication Doses .....................................................................................................................32
               Anticoagulation Schedules ........................................................................................................34










































               Updated 9/21/2018                                                                       page 5
   1   2   3   4   5   6   7   8   9   10